Summary
Boston Scientific Corporation (BSX) filed an 8-K report on May 13, 2012, detailing the results of its 2012 Annual Meeting of Stockholders held on May 8, 2012. The report indicates that all director nominees were elected to the Board for a one-year term. Additionally, stockholders approved the advisory vote on executive compensation, often referred to as 'Say-on-Pay,' and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year 2012. However, a notable outcome was the failure to approve the amendment and restatement of the Company's By-Laws that aimed to implement a majority vote standard in uncontested director elections. This suggests a divergence in shareholder sentiment regarding governance changes compared to routine business matters. Investors should note the strong support for the incumbent board and executive compensation, while also considering the implications of the rejected by-law amendment.
Key Highlights
- 1All director nominees were successfully elected to the Boston Scientific Board of Directors for a one-year term.
- 2The advisory vote on executive compensation ('Say-on-Pay') was approved by shareholders.
- 3Ernst & Young LLP was ratified as the company's independent registered public accounting firm for the 2012 fiscal year.
- 4An amendment to the By-Laws, intended to establish a majority vote standard for uncontested director elections, was not approved by shareholders.
- 5The election of directors saw very high 'For' votes, with over 1 billion shares in favor for each nominee.
- 6While the Say-on-Pay vote was approved, there was a significant number of 'Against' votes (over 332 million), indicating some shareholder dissent on executive compensation.